Prognostic factors in renal cell carcinoma.
Ljungberg
Börje
B
Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden. Borje.Ljungberg@urologi.umu.se
D002292:Carcinoma, Renal Cell / Q000235:genetics* / Q000401:mortality / Q000473:pathology*; D002869:Chromosome Aberrations; D019938:Cyclin D1 / Q000235:genetics; D018450:Disease Progression; D018572:Disease-Free Survival; D006801:Humans; D007668:Kidney / Q000473:pathology; D007680:Kidney Neoplasms / Q000235:genetics* / Q000401:mortality / Q000473:pathology*; D008207:Lymphatic Metastasis / Q000473:pathology; D009361:Neoplasm Invasiveness; D009364:Neoplasm Recurrence, Local / Q000235:genetics / Q000401:mortality / Q000473:pathology; D009367:Neoplasm Staging; D009360:Neoplastic Cells, Circulating; D011379:Prognosis; D018809:Proliferating Cell Nuclear Antigen / Q000235:genetics; D012333:RNA, Messenger / Q000235:genetics; D042461:Vascular Endothelial Growth Factor A / Q000235:genetics
C530104:CCND1 protein, human; D018809:Proliferating Cell Nuclear Antigen; D012333:RNA, Messenger; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; C413374:p27 antigen; D019938:Cyclin D1